Magnesium deserves more credit in the mental health conversation than it typically receives. It's the fourth most abundant mineral in the human body, it's involved in over 300 enzymatic reactions, and research consistently shows that a significant portion of the population — estimates vary, but some studies suggest upward of 50% in Western countries — is not getting adequate amounts from diet alone. That baseline deficiency matters because magnesium plays a direct role in regulating the HPA axis (the hormonal system responsible for your stress response), in NMDA receptor function (involved in mood and neuroplasticity), and in the production of serotonin and dopamine precursors.

A 2017 randomized trial published in PLOS ONE found that 248mg of elemental magnesium per day produced significant improvements in depression and anxiety scores within six weeks — and notably, the effects were consistent across age and gender. The researchers concluded the evidence was "sufficient to recommend" magnesium as a safe, accessible option for mild-to-moderate depression.

The form matters enormously here. Magnesium oxide, the cheapest and most common form in bargain supplements, has notoriously poor bioavailability — most of it passes through the gut without being absorbed. Magnesium glycinate (magnesium bound to the amino acid glycine) is consistently cited as the most bioavailable oral form and has the added benefit of being gentler on digestion. Magnesium L-threonate is a newer, pricier form that some researchers believe crosses the blood-brain barrier more readily — though the human trial data is still developing.

Typical studied doses range from 200–400mg of elemental magnesium per day. Watch for the distinction between elemental magnesium and total compound weight on supplement labels — a capsule of magnesium glycinate might weigh 500mg but only deliver 50–75mg of elemental magnesium. For reference, the magnesium glycinate in Yes! The Total Cortisol Reset provides 250mg per serving — a meaningful daily contribution in a well-absorbed form.

Side effects are minimal at standard doses. Very high doses can cause loose stools (magnesium has historically been used as a laxative at pharmaceutical doses). At 300–400mg/day in glycinate form, most people experience no GI issues. If you're on medications that affect kidney function, check with a prescriber first — magnesium clearance is renal-dependent.

Omega-3s have one of the largest and most consistent bodies of evidence of any supplement in the mood space — to the point where several major psychiatric associations now include them in their treatment guidelines as adjunctive options. A 2016 meta-analysis in Translational Psychiatry pooled data from 13 randomized controlled trials and found that omega-3 supplementation produced significant reductions in depressive symptoms, with EPA-dominant formulations showing stronger effects than DHA-dominant ones. This EPA vs. DHA distinction is one of the most commonly misunderstood details in the omega-3 conversation.

The working hypothesis for why omega-3s support mood involves multiple pathways: anti-inflammatory effects (chronic low-grade inflammation is increasingly implicated in depression), modulation of neurotransmitter signaling, and support for neuronal membrane integrity — essentially, the structural health of brain cells. EPA in particular appears to work more directly on the inflammatory and mood-regulating pathways, while DHA is more associated with structural brain development and neuroprotection.

For supplementation targeting mood, most researchers recommend formulations where EPA exceeds DHA, typically at a ratio of at least 2:1 EPA to DHA. Effective studied doses for mood range from 1,000–2,000mg of EPA per day, not total fish oil — again, a distinction the supplement label will need to make clear. A 1,000mg fish oil capsule might only contain 180mg of EPA and 120mg of DHA, meaning you'd need multiple capsules to hit the therapeutic range.

Look for products that are third-party tested for purity (heavy metals, especially mercury, are a real concern with lower-quality fish oil) and that disclose exact EPA and DHA content on the label. Algae-based omega-3s are a viable plant-based option — they're actually the original source that fish bioaccumulate from — and quality algae oil products can deliver meaningful EPA and DHA without the fishy aftertaste. Refrigerate opened fish oil to prevent oxidation, which can reduce efficacy and create the unpleasant rancid taste that makes people abandon the habit.

Omega-3s are generally safe at standard doses, though they can interact with blood thinners at high doses. Start at the lower end of the range and build up, and give it at least six weeks before evaluating effectiveness.

St. John's Wort is the supplement that essentially started the mainstream conversation about natural alternatives to antidepressants — and it has earned that position. A landmark Cochrane Review analyzing 29 clinical trials found that St. John's Wort was significantly more effective than placebo for mild-to-moderate depression and produced comparable results to standard antidepressants with fewer side effects in that population. That review covered over 5,000 participants. The evidence base here is genuinely substantial.

The active compounds most researched are hypericin and hyperforin, which appear to inhibit the reuptake of serotonin, dopamine, and norepinephrine — a broader mechanism than most SSRIs, which target serotonin primarily. Most quality St. John's Wort extracts are standardized to 0.3% hypericin and/or 1–4% hyperforin content. The typical studied dose is 300mg three times daily (900mg total) of a standardized extract, taken consistently over at least 4–6 weeks.

Here's where the responsible editorial note becomes critical: St. John's Wort has meaningful drug interactions that are not optional to understand before using it. It is a potent inducer of CYP3A4, a liver enzyme involved in metabolizing a very wide range of medications — including oral contraceptives, anticoagulants like warfarin, certain HIV medications, immunosuppressants, and ironically, some SSRIs. Co-administration with SSRIs can also cause serotonin syndrome, a potentially dangerous condition. If you are on any medication — any — this is the one supplement on this list where checking with a pharmacist before starting is genuinely non-negotiable, not just a legal disclaimer.

St. John's Wort is also not recommended during pregnancy and can increase photosensitivity. For people on no medications and dealing with mild-to-moderate low mood, it has a stronger evidence base than almost anything else on this list. For people on medications, the interaction profile makes it a non-starter unless specifically cleared by a prescriber. That honest framing is the only responsible way to present it.

Rhodiola occupies an interesting middle ground in the supplement research landscape — it has a more modest evidence base than saffron or St. John's Wort for depression specifically, but it has a reasonably consistent track record for what researchers call stress-induced low mood and fatigue. This distinction matters in practice because a meaningful percentage of people who self-identify as depressed are more accurately describing a state of chronic stress overwhelm, burnout, and exhaustion — a picture that Rhodiola's adaptogenic properties are well-suited to address.

Adaptogens are compounds that appear to help the body modulate its stress response — not by eliminating stress, but by improving resilience and recovery. Rhodiola's primary active compounds, rosavins and salidroside, have been studied for their effects on the HPA axis, cortisol regulation, and neurotransmitter activity. A 2015 study published in Phytomedicine directly compared Rhodiola to sertraline (a common SSRI) in patients with mild-to-moderate depression — Rhodiola produced smaller improvements in depression scores but was significantly better tolerated, with notably fewer adverse events.

The studied dose range is typically 200–600mg per day of a standardized extract (look for standardization to 3% rosavins and 1% salidroside — this is the ratio found in most clinical extracts). Many people report noticeable effects on energy and stress resilience within 1–2 weeks, which is faster than most other compounds on this list. One practical note: Rhodiola appears to be mildly stimulating for some people, particularly at higher doses. Taking it in the morning or early afternoon rather than at night is generally recommended to avoid any potential impact on sleep.

Side effects are generally mild — occasional dizziness or dry mouth, typically at higher doses. Rhodiola is generally considered safe for most healthy adults in the short-to-medium term. Long-term data beyond several months is less robust, which is worth noting if you're considering it as a foundation supplement rather than a short-term support. For someone navigating burnout, work stress, or the kind of low mood that feels more like depletion than sadness, Rhodiola is one of the more practical and well-tolerated options available.

SAMe is one of the more underappreciated entries in the natural mood supplement conversation, despite having a surprisingly robust evidence base. It's a compound the body produces naturally — a methyl donor involved in over 100 biochemical reactions, including the synthesis of neurotransmitters like serotonin, dopamine, and norepinephrine. When SAMe levels are adequate, neurotransmitter production runs more smoothly. When they're depleted — which can happen under chronic stress, poor diet, or certain genetic variants in methylation pathways — mood and cognitive function can suffer.

The clinical research is genuinely encouraging. A comprehensive review by the Agency for Healthcare Research and Quality found SAMe to be superior to placebo and comparable to tricyclic antidepressants for depression, with a more favorable side effect profile. More recent research has explored it as an augmentation strategy alongside conventional antidepressants — a 2010 Harvard study found that adding SAMe to SSRI treatment for patients who hadn't responded adequately produced significant improvements in depressive symptoms compared to placebo augmentation.

The effective studied dose range for mood is typically 400–1,600mg per day, usually split across two doses. SAMe is one of the pricier supplements on this list — quality matters significantly here, as SAMe is an unstable compound that degrades easily. Look for enteric-coated tablets (to protect from stomach acid), proper refrigeration during shipping, and a reputable manufacturer with stability testing. The tosylate salt form is the most common and well-studied; butanedisulfonate is another form used in some European clinical preparations.

A few cautions worth noting: SAMe can cause nausea and GI upset, particularly when starting — beginning at a lower dose and titrating up over 1–2 weeks reduces this. More importantly, SAMe is contraindicated in bipolar disorder, as it can trigger hypomanic or manic episodes. If there's any history of bipolar in your personal or family history, this is one to specifically discuss with a clinician before trying. For unipolar depression without contraindications, though, SAMe's combination of evidence base and tolerability makes it one of the more compelling natural options most people haven't heard of.

The relationship between vitamin D and mood is one of the most talked-about in functional medicine circles — and with good reason, though the nuance matters enormously here. The short version: if you are deficient in vitamin D, supplementing to correct that deficiency has meaningful evidence for improving depressive symptoms. If you are already in adequate range, the evidence for supplementation producing additional mood benefits is considerably weaker. That distinction gets lost in a lot of wellness content, so it's worth being direct about it.

Vitamin D receptors are found throughout the brain, including in regions heavily involved in mood regulation like the hippocampus and prefrontal cortex. Vitamin D also plays a role in the synthesis of serotonin and dopamine. Population studies consistently find higher rates of depression in people with low vitamin D levels, and the seasonal affective pattern — low mood in winter months when sun exposure drops — is one of the most intuitive examples of this relationship. A 2020 meta-analysis in Critical Reviews in Food Science and Nutrition found that vitamin D supplementation significantly reduced depressive symptoms across 25 randomized controlled trials.

The practical starting point: get your 25-OH vitamin D level tested before supplementing aggressively. This is a standard blood test most primary care doctors can order. Deficiency is generally defined as below 20 ng/mL; insufficiency as 20–29 ng/mL; sufficiency as 30–80 ng/mL. A significant portion of the population, particularly in northern latitudes, darker-skinned individuals (melanin reduces UV synthesis), people who work indoors, and older adults, falls below the sufficiency threshold without knowing it.

If deficient, a common supplementation protocol is 2,000–5,000 IU of vitamin D3 per day (D3, not D2, which is less bioavailable) taken with a fat-containing meal. Many practitioners also recommend pairing it with vitamin K2 (MK-7 form), which helps direct calcium metabolism appropriately when D levels are being raised. At very high doses (above 10,000 IU/day sustained), toxicity is possible — fat-soluble vitamins accumulate. At the 2,000–4,000 IU range for most deficient adults, this is a safe, inexpensive, and frequently impactful intervention. Retest levels after 3 months to calibrate.